Clinical Trials
Clinical Trials

Our Current Trials

A Phase I/II Study of FCX-007 (Genetically-Modified Autologous Human Dermal Fibroblasts) for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

This Phase I/II trial is currently recruiting adult patients.

Learn more